Clinical trial
The Effects of Dietary Supplementation Allicor on the Effectiveness of Treatment of Patients After Coronary Arteria Revascularization
NCT05803759 is registered in ClinicalTrials.gov with Institute for Atherosclerosis Research, Russia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effects of Dietary Supplementation Allicor on the Effectiveness of Treatment of Patients After Coronary Arteria Revascularization
- Lead sponsor
- Institute for Atherosclerosis Research, Russia
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- April 10, 2023
- Completion date
- March 31, 2025
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coronary arteriosclerosis, coronary artery bypass grafting, myocardial ischemia, percutaneous coronary revascularization